Scarica l'app Stockscreener
2.08
0.72%
0.01
Precedente Chiudi:
$2.07
Aprire:
$2.08
Volume 24 ore:
30,412
Relative Volume:
0.11
Capitalizzazione di mercato:
$36.04M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.24%
1M Prestazione:
+0.24%
6M Prestazione:
+102.43%
1 anno Prestazione:
-39.74%
Intervallo 1D:
$2.07
$2.09
Intervallo di 1 settimana:
$2.07
$2.09
Portata 52W:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.08 | 35.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.20 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.43 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.50 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.14 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
Trium Capital discloses 11% stake in Mural Oncology By Investing.com - Investing.com South Africa
Trium Capital discloses 11% stake in Mural Oncology - Investing.com
Is Mural Oncology plc stock attractive for growth ETFsShare Buyback & Growth Focused Stock Reports - newser.com
What candlestick patterns are forming on Mural Oncology plcMarket Activity Report & Safe Entry Momentum Tips - newser.com
Exit strategy if you’re trapped in Mural Oncology plc2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com
Visualizing Mural Oncology plc stock with heatmapsMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Does Mural Oncology plc qualify in momentum factor screeningPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Citadel Group discloses 1.35% position in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.35% position in Mural Oncology - Investing.com India
Combining machine learning predictions for Mural Oncology plcEarnings Recap Summary & Fast Entry High Yield Tips - newser.com
What recovery options are there for Mural Oncology plcJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
Citadel Group discloses 1.34% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.34% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.33% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.33% stake in Mural Oncology - Investing.com
Detecting support and resistance levels for Mural Oncology plc2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
What MACD signals say about Mural Oncology plcJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
Visual trend scoring systems applied to Mural Oncology plc2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Will Mural Oncology plc outperform the marketMarket Activity Recap & Precise Buy Zone Tips - newser.com
News impact scoring models applied to Mural Oncology plcQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Will Mural Oncology plc continue its uptrendWeekly Investment Summary & AI Optimized Trade Strategies - newser.com
Quantitative breakdown of Mural Oncology plc recent moveQuarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Is Mural Oncology plc stock undervalued vs historical averagesTrade Ideas & Risk Managed Investment Entry Signals - newser.com
Cancer stocks rebound, outpacing broader markets in Q3 2025 - BioWorld MedTech
Citadel Group discloses 1.32% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 1.32% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.56% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.56% stake in Mural Oncology - Investing.com India
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Mural Oncology Plc Azioni (MURA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):